ABMC Financials 07/16/2014 11:37:33
American Bio Medica Corp.
Period Ending Dec 31, 2013 Dec 31, 2012 Dec 31, 2011 Dec 31, 2010
Total Revenue 8,894 9,343 9,272 10,421
Cost of Revenue 5,322 5,999 5,396 6,313
Gross Profit 3,572 3,344 3,876 4,108
Operating Expenses
Research and Development 645 207 223 297
Sales, General and Admin. 4,058 4,066 3,799 4,345
Non-Recurring Items - - - -
Other - - - -
Operating Income (1,131) (929) (146) (534)
Income From Continuing Operations
Add'l Income/Expense Items 655 10 9 4
Earnings Before Interest and Tax (476) (919) (137) (530)
Interest Expense 310 194 198 216
Earnings Before Tax (786) (1,113) (335) (746)
Income Tax 2 (2) 10 4
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (788) (1,111) (345) (750)
Non Recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (788) (1,111) (345) (750)
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders (788) (1,111) (345) (750)